Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression

Molecular Psychiatry

Volumn 19, Issue 2, 2014, Pages 235-242

  Lawal, H O ^a   Terrell, A ^a   Lam, H A ^a   Djapri, C ^a   Jang, J ^a   Hadi, R ^a   Roberts, L ^a   Shahi, V ^a   Chou, M T ^a   Biedermann, T ^a   Huang, B ^a   Lawless, G M ^a   Maidment, N T ^a   Krantz, D E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADHD; antidepressant; neurotransmitter transporter; Parkinson's disease; VMAT

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMINE; BETHANECHOL; BRUCINE; CARBACHOL; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; DACARBAZINE; DESIPRAMINE; HYDRASTININE; HYOSCYAMINE; IMIPRAMINE; ISOPROPAMIDE IODIDE; NORGESTREL; PERGOLIDE; PINDOLOL; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER; ACETAZOLAMIDE; AMIKACIN; AMPHETAMINE; ANTINEOPLASTIC AGENT; BETAMETHASONE; CYCLOPENTOLATE; DEXAMETHASONE; DIFLUNISAL; EPINASTINE; GALLIC ACID; MIANSERIN; NORADRENALIN; OCTOPAMINE; PSYCHOSTIMULANT AGENT; TESTOSTERONE; UNINDEXED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DROSOPHILA; DRUG IDENTIFICATION; DRUG SCREENING; EXPERIMENTAL HYPOACTIVITY; FEMALE; FERTILITY; GENE MUTATION; IN VIVO STUDY; LARVA; LOCOMOTION; MALE; MUTANT DROSOPHILA; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; ANALYTIC METHOD; ATTENTION DEFICIT DISORDER; DOSE RESPONSE; DROSOPHILA MELANOGASTER; DROSOPHILA MODIFIER; EGG LAYING; MUTATION; OOCYTE DEVELOPMENT; STORAGE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIPARKINSON AGENTS; DACARBAZINE; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; DRUG EVALUATION, PRECLINICAL; FEMALE; FERTILITY; LARVA; LOCOMOTION; MALE; MUTATION; PARKINSON DISEASE; PERGOLIDE; SYNAPSES; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84893643261     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.170     Document Type: Article

References (37)

1. Chaudhry FA, Boulland JL, Jenstad M, Bredahl MK, Edwards RH. Pharmacology of neurotransmitter transport into secretory vesicles. Handb Exp Pharmacol 2008; 184: 77-106.
2. Hastings TG, Lewis DA, Zigmond MJ. Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol 1996; 387: 97-106.
3. Guillot TS, Miller GW. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Mol Neurobiol 2009; 39: 149-170.
4. Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL et al. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 2007; 27: 8138-8148.
5. Sang TK, Chang HY, Lawless GM, Ratnaparkhi A, Mee L, Ackerson LC et al. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine. J Neurosci 2007; 27: 981-992.
6. Lawal HO, Chang HY, Terrell AN, Brooks ES, Pulido D, Simon AF et al. The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons. Neurobiol Dis 2010; 40: 102-112.
7. Freis ED. Mental depression in hypertensive patients treated for long periods with high doses of reserpine. N Engl J Med 1954; 251: 1006-1008.
8. Fukui M, Rodriguiz RM, Zhou J, Jiang SX, Phillips LE, Caron MG et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci 2007; 27: 10520-10529.
9. Chang H-Y, Grygoruk A, Brooks ES, Ackerson LC, Maidment NT, Bainton RJ et al. Over-expression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol Psychiatry 2006; 11: 99-113.
10. Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005; 75: 406-433.
11. Bier E. Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 2005; 6: 9-23.
12. Simon AF, Daniels R, Romero-Caldero'n R, Grygoruk A, Chang HY, Najibi R et al. Drosophila vesicular monoamine transporter mutants can adapt to reduced or eliminated vesicular stores of dopamine and serotonin. Genetics 2009; 181: 525-541.
13. Monastirioti M, Linn CEJ, White K. Characterization of Drosophila tyramine betahydroxylase gene and isolation of mutant flies lacking octopamine. J Neurosci 1996; 16: 3900-3911.
14. Fox LE, Soll DR, Wu CF. Coordination and modulation of locomotion pattern generators in Drosophila larvae: effects of altered biogenic amine levels by the tyramine Beta hydroxlyase mutation. J Neurosci 2006; 26: 1486-1498.
15. Suo S, Kimura Y, Van Tol HH. Starvation induces cAMP response element-binding protein-dependent gene expression through octopamine-Gq signaling in Caenorhabditis elegans. J Neurosci 2006; 26: 10082-10090.
16. Pizzo AB, Karam CS, Zhang Y, Yano H, Freyberg RJ, Karam DS et al. The membrane- raft protein Flotillin-1 is essential in dopamine neurons for amphetamineinduced behavior in Drosophila. Mol Psychiatry advance online publication, 19 June 2012; doi:10.1038/mp.2012.82 (e-pub ahead of print).
17. Gorczyca MG, Budnik V, White K, Wu CF. Dual muscarinic and nicotinic action on a motor program in Drosophila. J Neurobiol 1991; 22: 391-404.
18. Rohrbough J, O'Dowd DK, Baines RA, Broadie K. Cellular bases of behavioral plasticity: establishing and modifying synaptic circuits in the Drosophila genetic system. J Neurobiol 2003; 54: 254-271.
19. Bonfante V, Santoro A, Viviani S, Valagussa P, Bonadonna G. ABVD in the treatment of Hodgkin's disease. Semin Oncol 1992; 19(2 Suppl 5): 38-44, discussion 44-35.
20. Monastirioti M. Distinct octopamine cell population residing in the CNS abdominal ganglion controls ovulation in Drosophila melanogaster. Dev Biol 2003; 264: 38-49.
21. Middleton A, Nongthomba U, Parry K, Sweeney ST, Sparrow JC, Elliott CJ. Neuromuscular organization and aminergic modulation of contractions in the Drosophila ovary. BMC Biol 2006; 4: 17.
22. Lee HG, Seong CS, Kim YC, Davis RL, Han KA. Octopamine receptor OAMB is required for ovulation in Drosophila melanogaster. Dev Biol 2003; 264: 179-190.
23. Lee HG, Rohila S, Han KA. The octopamine receptor OAMB mediates ovulation via Ca2/calmodulin-dependent protein kinase II in the Drosophila oviduct epithelium. PLoS One 2009; 4: e4716.
24. Willard SS, Koss CM, Cronmiller C. Chronic cocaine exposure in Drosophila: life, cell death and oogenesis. Dev Biol 2006; 296: 150-163.
25. Unoki S, Matsumoto Y, Mizunami M. Participation of octopaminergic reward system and dopaminergic punishment system in insect olfactory learning revealed by pharmacological study. Eur J Neurosci 2005; 22: 1409-1416.
26. Ohtani A, Arai Y, Ozoe F, Ohta H, Narusuye K, Huang J et al. Molecular cloning and heterologous expression of an alpha-adrenergic-like octopamine receptor from the silkworm Bombyx mori. Insect Mol Biol 2006; 15: 763-772.
27. Radad K, Gille G, Rausch WD. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. Pharmacol Rep 2005; 57: 701-712.
28. Saraswati S, Fox LE, Soll DR, Wu CF. Tyramine and octopamine have opposite effects on the locomotion of Drosophila larvae. J Neurobiol 2004; 58: 425-441.
29. Pourahmad J, Amirmostofian M, Kobarfard F, Shahraki J. Biological reactive intermediates that mediate dacarbazine cytotoxicity. Cancer Chemother Pharmacol 2009; 65: 89-96.
30. Gaidhu MP, Fediuc S, Ceddia RB. 5-Aminoimidazole-4-carboxamide-1-beta- Dribofuranoside- induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J Biol Chem 2006; 281: 25956-25964.
31. Stork T, Engelen D, Krudewig A, Silies M, Bainton RJ, Klambt C. Organization and function of the blood-brain barrier in Drosophila. J Neurosci 2008; 28: 587-597.
32. Greer CL, Grygoruk A, Patton DE, Ley B, Romero-Caldero'n R, Chang H-Y et al. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin and octopamine. J Neurobiol 2005; 64: 239-258.
33. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave JJ. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 1992; 66: 198-203.
34. Cubeddu LX. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients. Oncology 1996; 53(Suppl 1): 18-25.
35. Boon H, Bosselaar M, Praet SF, Blaak EE, Saris WH, Wagenmakers AJ et al. Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia 2008; 51: 1893-1900.
36. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y et al. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 2009; 62: 218-229.
37. Glatt CE, Wahner AD, White DJ, Ruiz-Linares A, Ritz B. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Hum Mol Genet 2006; 15: 299-305.